Hiroko Maruyama
Scripps Research Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroko Maruyama.
Journal of Immunological Methods | 1999
Ichiro Kuwabara; Hiroko Maruyama; Seiki Kamisue; Midori Shima; Akira Yoshioka; Ichi N. Maruyama
Haemophilia A patients who receive repeated transfusion of fVIII concentrates often develop inhibitor alloantibodies, resulting in reduced efficacy of the therapy. Determination of fVIII epitopes for the alloantibodies is essential for an understanding of their inhibitory effect on blood coagulation. Random fragments of fVIII displayed on lambda phage particles were selected using two patient plasmas immobilized onto the surface of a microtiter plate. A set of clones defined the minimal domain that consisted of 157 amino acid residues including cysteine at both boundaries. The minimal domain absorbed most of the binding activities of the plasmas to fVIII, suggesting that the domain contains a major determinant for the plasmas. Site-directed mutagenesis and chemical denaturation of the domain confirmed that a tertiary structure formed by the disulfide bridge was recognized by the antibodies. The epitope domain defined overlaps with fVIII binding sites to vWf and phospholipid, and may play an important role in blood coagulation. Thus, the bacteriophage lambda surface display may be useful for mapping the minimal folding domain of various protein antigens that contain a conformational epitope.
Gene | 2000
Mikio Niwa; Hiroko Maruyama; Takashi Fujimoto; Kazuhiro Dohi; Ichi N. Maruyama
Abstract Bacteriophage λ surface display was used to isolate cDNA clones encoding autoantigens recognized by sera from patients with Sjogrens syndrome (SS). We made cDNA libraries from human HeLa and HepG2 cells, using the expression vector λfoo. By repeating affinity selection of the libraries with the sera immobilized in microtiter wells, we isolated three clones that encode previously unknown antigens as well as four clones previously known as SS autoantigens. The newly identified autoantigens include TRK-fused gene product (TFG), survival motor neuron gene product (SMN) and pM5, which has a similarity to the metal-binding domain of human fibroblast collagenase. Thus, the bacteriophage λ surface display is powerful for isolating cDNA clones by affinity screening.
Neuroscience | 2001
Hiroko Maruyama; Terese L. Rakow; Ichi N. Maruyama
C. elegans mutants defective in unc-13 exhibited severe behavioral abnormalities including paralyzed locomotion and slow pharyngeal pumping and irregular defecation cycle. Consistent with the phenotypes, the mutants accumulated abnormally high levels of the neurotransmitter acetylcholine and were resistant to acetylcholinesterase inhibitors. The unc-13 gene was expressed in most, if not all, neurons when analyzed by using chimeric constructs consisting of the unc-13 promoter and green fluorescence protein or beta-galactosidase reporter gene. While Ca(2+)-regulated acetylcholine release is lacking, the mutants were still able to release acetylcholine in vivo and in vitro at similar levels to that mediated by the regulated mechanism. Double mutants defective in both unc-13 and other genes involved in synaptic transmission showed the Unc-13 phenotype, rather than other mutant phenotypes, in terms of locomotion as well as of acetylcholine accumulation. Furthermore, electron microscopic reconstruction of the mutant nervous system uncovered that a majority of neurons developed and connected as those in the wild type except for subtle abnormalities including inappropriate connections through gap junctions and morphological alterations of neurons. These results demonstrate that the unc-13 gene product plays an essential role at a late stage in Ca(2+)-regulated synaptic exocytosis. Neurotransmitters released through the Ca(2+)-regulated mechanism are required for, but do not play major roles in the nervous system development. The large amount of Ca(2+)-independent neurotransmitter release observed in the unc-13 mutants suggests that there may be a distinct mechanism from evoked or spontaneous release in neurotransmission.
Journal of Molecular Biology | 2001
Takanori Moriki; Hiroko Maruyama; Ichi N. Maruyama
Nucleic Acids Research | 1995
Ichiro N. Maruyama; Terese L. Rakow; Hiroko Maruyama
Molecular Biology of the Cell | 2000
Rebecca Eustance Kohn; Janet S. Duerr; John McManus; Angie Duke; Terese L. Rakow; Hiroko Maruyama; Gary Moulder; Ichi N. Maruyama; Robert Barstead; James B. Rand
Archive | 1994
Ichiro N. Maruyama; Hiroko Maruyama; Sydney Brenner
Journal of Molecular Biology | 1995
Ichiro N. Maruyama; Gi Y. Mikawa; Hiroko Maruyama
Nature Biotechnology | 1997
Ichiro Kuwabara; Hiroko Maruyama; Y. Gi Mikawa; Riaz I. Zuberi; Fu Tong Liu; Ichi N. Maruyama
Archive | 1997
Ichiro N. Maruyama; Hiroko Maruyama; Sydney Brenner